Central Nervous System Metastases in Breast Cancer
Current Treatment Options in Oncology · 2025
DOI: 10.1007/s11864-024-01286-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2025. Verfasst von Thomas Grinda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Breast Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Central Nervous System Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 120 Literaturangaben.
Abstract (Originalsprache)
OPINION STATEMENT: Breast cancer metastasizing to the central nervous system (CNS) encompasses two distinct entities: brain metastases involving the cerebral parenchyma and infiltration of the leptomeningeal space, i.e., leptomeningeal disease. CNS metastases affect 10-15% of patients with hormone receptor-positive-status and nearly one-half of those with HER2-positive and triple-negative breast cancer with distant metastatic disease. Significant clinical morbidity and heterogeneous penetration of the blood-brain barrier by systemic therapies contribute to the poor prognosis associated with brain metastases. Recent advances in radiotherapy, including stereotactic approaches and morbidity-reducing strategies such as the use of memantine and hippocampal avoidance in whole brain radiation, coupled with the development of more effective CNS-penetrant systemic therapies, including small molecules and antibody-drug conjugates, have significantly improved patient outcomes. Consequently, patients with breast cancer CNS metastases have improved survival compared to prior decades, and longitudinal care has become increasingly complex, necessitating a multidisciplinary approach to achieve optimal outcomes for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Breast Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
- Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
- Harvard Medical School, Boston, MA, USA.
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.
- Breast Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. sarahl_sammons@dfci.harvard.edu.
- Harvard Medical School, Boston, MA, USA. sarahl_sammons@dfci.harvard.edu.
Zitieren
APA
Grinda, T., Aizer, A. A., Lin, N. U., & Sammons, S. L. (2025). Central Nervous System Metastases in Breast Cancer. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01286-1
Vancouver
Grinda T, Aizer AA, Lin NU, Sammons SL. Central Nervous System Metastases in Breast Cancer. Current Treatment Options in Oncology. 2025. doi:10.1007/s11864-024-01286-1
BibTeX
@article{Grinda2025,
author = {Grinda, Thomas and Aizer, Ayal A and Lin, Nancy U and Sammons, Sarah L},
title = {Central Nervous System Metastases in Breast Cancer},
journal = {Current Treatment Options in Oncology},
year = {2025},
doi = {10.1007/s11864-024-01286-1}
}
EUVIMED